Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness

Aging Cell

Volumn 11, Issue 5, 2012, Pages 876-884

  Weiss, Edward P ^a,b   Villareal, Dennis T ^a,c   Ehsani, Ali A ^a,d   Fontana, Luigi ^a,e,f   Holloszy, John O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF SALERNO   (Italy)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Aging; Augmentation index; Vasculature

Indexed keywords

INTERLEUKIN 6; PRASTERONE; SEX HORMONE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; AGING; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR RISK; CAROTID AUGMENTATION INDEX; CAROTID FEMORAL PULSE WAVE VELOCITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; BLOOD FLOW VELOCITY; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84866454494     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2012.00852.x     Document Type: Article

References (44)

1. Altman R, Motton DD, Kota RS, Rutledge JC (2008) Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul. Pharmacol. 48, 76-84.
2. Alwardt CM, Yu Q, Brooks HL, McReynolds MR, Vazquez R, Watson RR, Larson DF (2006) Comparative effects of dehydroepiandrosterone sulfate on ventricular diastolic function with young and aged female mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R251-R256.
3. Barrett-Connor E, Khaw K-T, Yen SSC (1986) A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med. 315, 1519-1524.
4. Berr C, Lafont S, Debuire B, Dartigues J-F, Baulieu E-E (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a french community-based study. Proc. Natl. Acad. Sci. U S A 93, 13410-13415.
5. 2/NFAT axis. Circulation 120, 1231-1240.
6. Cohn JN (2006) Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 113, 601-603.
7. Dockery F, Bulpitt CJ, Agarwal S, Donaldson M, Rajkumar C (2003a) Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin. Sci. (Lond.) 104, 195-201.
8. Dockery F, Bulpitt CJ, Donaldson M, Fernandez S, Rajkumar C (2003b) The relationship between androgens and arterial stiffness in older men. J. Am. Geriatr. Soc. 51, 1627-1632.
9. Fukui M, Ose H, Kitagawa Y, Yamazaki M, Hasegawa G, Yoshikawa T, Nakamura N (2007) Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus. Metabolism 56, 1167-1173.
10. INK4A. J. Clin. Invest. 115, 3228-3238.
11. Han SH, Quon MJ, Koh KK (2005) Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptorα activators. Hypertension 46, 1086-1092.
12. Hornsby PJ (1995) Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann. N. Y. Acad. Sci. 774, 29-46.
13. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ (2006) Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am. J. Physiol: Endocrinol. Metab. 290, E234-E242.
14. Iwasaki T, Mukasa K, Yoneda M, Ito S, Yamada Y, Mori Y, Fujisawa N, Fujisawa T, Wada K, Sekihara H, Nakajima A (2005) Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. Am. J. Physiol: Endocrin. Metab. 288, E1222-E1228.
15. Karamanoglu M (2003) Errors in estimating propagation distances in pulse wave velocity. Hypertension 41, e8.
16. Kasai T, Miyauchi K, Yokoyama T, Aihara K, Daida H (2006) Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models. Atherosclerosis 188, 274-280.
17. Kohl HW, Blair SN, Paffembarger RS, Macera CA, Kroonenfeld JJ (1997) A Collection of Physical Activity Questionnaires for Health-Related Research: The aerobics center longitudinal study physical activity questionnaire. Med. Sci. Sports Exerc. 29(6 Suppl), 10-14.
18. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37, 1236-1241.
19. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27, 2588-2605.
20. LeFebvre P, Chinetti G, Fruchart J-C, Staels B (2006) Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. J. Clin. Invest. 116, 571-580.
21. i2, 3. J. Biol. Chem. 277, 21379-21388.
22. Liu D, Si H, Reynolds KA, Zhen W, Jia Z, Dillon JS (2007) Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148, 3068-3076.
23. Mazat L, Lafront S, Berr C, Debuire B, Tessier JF, Dartigues JF, Baulieu EE (2001) Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci. USA 98, 8145-8150.
24. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59, 551-555.
25. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H (1992) Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75, 1002-1004.
26. Peters JM, Zhou YC, Ram PA, Lee SS, Gonzalez FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Mol. Pharmacol. 50, 67-74.
27. Poynter ME, Daynes RA (1998) Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-kB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273, 32833-32841.
28. Rice SP, Agarwal N, Bolusani H, Newcombe R, Scanlon MF, Ludgate M, Rees DA (2009) Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J. Clin. Endocrinol. Metab. 94, 1966-1972.
29. Ryan KE, McCance DR, Powell L, McMahon R, Trimble ER (2007) Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis 194, e123-e130.
30. Staels B, Fruchart J-C (2005) Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460-2470.
31. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A (2005) Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111, 3384-3390.
32. Tamasi V, Miller KK, Ripp SL, Vila E, Geoghagen TE, Prough RA (2008) Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators. Mol. Pharmacol. 73, 968-976.
33. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP (2009) Anti-inflammatory effects of fibrates: an overview. Curr. Med. Chem. 16, 676-684.
34. Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG (1993) Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 88(4 Pt 1), 1456-1462.
35. Villareal DT, Holloszy JO (2004) Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292, 2243-2248.
36. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C (2010a) Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur. Heart J. 31, 1865-1871.
37. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010b) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55, 1318-1327.
38. Weiss EP, Shah K, Fontana L, Lambert CP, Holloszy JO, Villareal DT (2009) Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am. J. Clin. Nutr. 89, 1459-1467.
39. Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO (2011) Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY) 3, 533-542.
40. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J. Physiol. 525(Pt 1), 263-270.
41. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Cockcroft JR (2002) Heart rate dependency of pulse pressure amplification and arterial stiffness. Am. J. Hypertens. 15(1 Pt 1), 24-30.
42. Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li H, Liu JP, Funder JW, Sudhir K, Komesaroff PA (2002s) Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J. Clin. Endocrinol. Metab. 87, 176-181.
43. Williams MRI, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K, Komesaroff PA (2004) Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J. Clin. Endocrinol. Metab. 89, 4708-4715.
44. Yaron M, Greenman Y, Rosenfeld JB, Izkhakov E, Limor R, Osher E, Shenkerman G, Tordjman K, Stern N (2009) Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur. J. Endocrinol. 160, 839-846.